Dalrada Financial Corporation (DFCO) reported Q4 2023 revenue of $10.75 million, up 152.56% year-over-year and 114.29% quarter-over-quarter, signaling meaningful top-line momentum after a period of softer demand. Despite the revenue surge, the company posted an operating loss of $9.58 million and a net loss of $8.24 million, yielding an EPS of -$0.0929. The negative profitability was driven by a high fixed cost base and elevated general and administrative expenses totaling $11.03 million, contributing to an EBITDA of -$8.41 million and an EBITDA margin of -78.2%. Gross margin stood at 18.6% with gross profit of $1.999 million, indicating improving top-line absorption but limited leverage from cost of goods sold relative to the overall expense base.
On the cash flow front, Dalrada generated $5.46 million of operating cash flow (OCF) and $5.26 million of free cash flow, aided by working capital movements despite the net loss backdrop. Cash and cash equivalents at period-end were $0.813 million, with total debt of $8.4339 million and net debt of $7.621 million. The balance sheet shows total assets of $25.17 million and total liabilities of $20.92 million, resulting in equity of $4.11 million. Notably, retained earnings are deeply negative at approximately $141.73 million, underscoring a long-standing deficit rather than a recently material cure. The current ratio is just under 1.0 (0.98) and the quick ratio sits at 0.772, indicating tighter short-term liquidity despite positive quarterly OCF.
Looking forward, management has not provided explicit forward guidance within the data set. The near-term investment thesis hinges on achieving operating leverage from revenue scale while stabilizing cost structures, reducing debt service burdens, and converting operating cash flow gains into sustainable profitability. The key questions for investors are whether Dalrada can sustain top-line growth without proportionally higher overhead, and whether it can meaningfully deleverage to improve liquidity and interest coverage. Key catalysts to monitor include revised cost controls, efficiency improvements across segments, and any strategic actions that monetize non-core assets or reallocate capital toward higher-return opportunities.
Key Performance Indicators
Revenue
10.75M
QoQ: 114.29% | YoY:152.56%
Gross Profit
2.00M
18.58% margin
QoQ: 105.85% | YoY:5.10%
Operating Income
-9.58M
QoQ: -88.94% | YoY:-224.15%
Net Income
-8.24M
QoQ: -71.01% | YoY:-134.19%
EPS
-0.09
QoQ: -72.04% | YoY:-90.76%
Revenue Trend
Margin Analysis
Key Insights
Net cash provided by operating activities: 5,461,911
No earnings call transcript was provided in the data. As a result, there are no management quotes or transcript-driven thematic highlights available within this dataset. Analysts should supplement this section with verbatim quotes and themes from the actual call to enrich the narrative around strategy, execution, and market conditions.
N/A
— N/A
N/A
— N/A
Forward Guidance
There is no explicit forward guidance in the provided data. If Dalrada issues forward targets in follow-on communications, investors should evaluate them against the backdrop of:
- Need for sustained operating leverage: Revenue growth must outpace fixed-cost expansion to translate into positive EBITDA and net income.
- Leverage and liquidity trajectory: With net debt of approximately $7.62 million and a current ratio near 1x, debt service capacity and liquidity risk are pivotal monitoring factors.
- Margin expansion opportunities: Any potential improvement in gross margin (beyond current 18.6%) and a disciplined approach to G&A could materially affect profitability.
- Capital allocation: Cash flow generation is currently driven by working capital changes; the durability of this source of cash flow and its sustainability under varying demand conditions is crucial.
- Industry and product mix execution: Success in clean energy, healthcare technology, and related engineering services hinges on competitive differentiation, contract wins, and operating efficiency.
Key factors investors should monitor include monthly revenue run-rate trajectories, quarterly expense control milestones, debt maturity schedules, and any asset monetization initiatives that could bolster liquidity.
Competitive Position
Company
Gross Margin
Operating Margin
Return on Equity
P/E Ratio
DFCO Focus
18.58%
-89.10%
-2.00%
-47.80%
DCAC
35.90%
-19.50%
5.31%
-92.40%
AIMH
0.00%
0.00%
0.00%
-99.60%
SAKL
37.40%
-18.50%
0.69%
-2.27%
AERS
0.00%
0.00%
4.76%
-130.79%
Gross Profit Margin
Operating Profit Margin
Return on Equity
P/E Ratio Comparison
Investment Outlook
Dalrada’s QQ4 2023 results depict robust top-line growth alongside a structurally unprofitable cost base, elevated leverage, and tight liquidity. The investment thesis remains high risk until the company demonstrates sustainable profitability and a clear path to deleveraging. Positive indicators include meaningful OCF and FCF generation amid losses, suggesting potential for liquidity stabilization if cost controls and revenue mix improvements are achieved. Key catalysts include successful cost rationalization, margin expansion, reduced debt service burden, and any strategic actions that monetize non-core assets or unlock higher-margin opportunities. For risk-tolerant investors, a constructive entry would require visibility into a credible plan to achieve sustained earnings power and a credible capital allocation strategy to strengthen the balance sheet and stabilize cash flows.
Key Investment Factors
Growth Potential
Dalrada’s diversified industrials footprint (clean energy, healthcare technology, education services) offers potential revenue diversification and cross-selling opportunities, particularly if the company can commercialize software and advanced solutions at scale and improve contract-win rates in higher-margin segments.
Profitability Risk
Sustained net losses and negative EBITDA; elevated G&A and operating expenses; constrained liquidity with current ratio near 1x; high leverage (debt to equity ~2.05) and negative interest coverage; dependence on working capital adjustments for cash flow; exposure to OTC market liquidity risk; long-term deficit embedded in retained earnings.
Financial Position
Balance sheet shows modest asset base ($25.17M) but a deep accumulated deficit (-$141.73M) and net debt of $7.62M. Positive OCF and free cash flow suggest some cash-generation capacity, but profitability remains elusive. Liquidity metrics are tight (current ratio 0.98; quick ratio 0.772); debt-service burden and impaired earnings limit financial flexibility.
SWOT Analysis
Strengths
YoY revenue growth of 152.56% and QoQ growth of 114.29% indicate meaningful top-line momentum in QQ4 2023.
Positive operating cash flow and free cash flow despite a net loss, reflecting working capital benefits and potential near-term liquidity relief.
Diversified business lines across engineering, health IT, education, and other services provide optionality and potential cross-sell opportunities.
Weaknesses
Persistent net losses and negative EBITDA (EBITDA -$8.41M; margin -78.17%) undermine earnings quality.
Negative retained earnings (-$141.73M) and a high accumulated deficit signal structural runway and equity compression.
Tight liquidity metrics (current ratio ~1x) and leverage (debt-to-equity ~2.05) elevate financial risk.
Opportunities
Scale potential in clean energy solutions and energy harvesting/recycling applications with advanced technology offerings.
Operational improvements and cost rationalization could unlock higher EBITDA margins and cash conversion.
Strategic partnerships or asset monetization could enhance liquidity and reduce leverage.
Threats
Market volatility in Industrials/consulting services and dependence on contract-driven revenue could pressure margins.
High interest burden and a potential need for refinancings could constrain financial flexibility.
OTC liquidity risk and a small-cap profile may limit access to capital and analyst coverage.